PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E11.36 EPS (ttm)4.43 Insider Own0.04% Shs Outstand5.62B Perf Week1.92%
Market Cap285.45B Forward P/E9.51 EPS next Y5.30 Insider Trans-11.70% Shs Float5.54B Perf Month0.44%
Income25.42B PEG- EPS next Q1.98 Inst Own68.50% Short Float1.23% Perf Quarter1.45%
Sales92.37B P/S3.09 EPS this Y233.60% Inst Trans0.30% Short Ratio2.41 Perf Half Y1.61%
Book/sh14.67 P/B3.44 EPS next Y-22.36% ROA14.00% Target Price59.33 Perf Year26.54%
Cash/sh4.22 P/C11.95 EPS next 5Y-0.80% ROE32.70% 52W Range38.47 - 61.71 Perf YTD-14.65%
Dividend1.60 P/FCF12.42 EPS past 5Y27.40% ROI18.90% 52W High-18.44% Beta0.73
Dividend %3.17% Quick Ratio1.10 Sales past 5Y9.00% Gross Margin60.40% 52W Low30.81% ATR1.46
Employees79000 Current Ratio1.40 Sales Q/Q76.80% Oper. Margin30.30% RSI (14)50.45 Volatility2.66% 2.96%
OptionableYes Debt/Eq0.44 EPS Q/Q58.80% Profit Margin27.00% Rel Volume0.54 Prev Close50.40
ShortableYes LT Debt/Eq0.43 EarningsMay 03 BMO Payout35.30% Avg Volume28.18M Price50.33
Recom- SMA201.72% SMA50-1.74% SMA2001.16% Volume6,600,444 Change-0.14%
Apr-06-22Resumed Morgan Stanley Equal-Weight $55
Jan-05-22Upgrade BofA Securities Neutral → Buy $59 → $70
Jan-03-22Reiterated Bernstein Mkt Perform $44 → $65
Dec-20-21Reiterated Cowen Outperform $56 → $70
Dec-17-21Initiated Goldman Neutral $51
Dec-13-21Upgrade UBS Neutral → Buy $52 → $60
Dec-09-21Initiated Wells Fargo Overweight $60
Nov-19-21Initiated BMO Capital Markets Outperform $60
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
May-19-22 11:37AM  
06:20AM  
May-18-22 12:21PM  
11:53AM  
10:10AM  
10:07AM  
09:39AM  
06:30AM  
02:56AM  
May-17-22 04:01PM  
04:00PM  
03:52PM  
03:41PM  
02:55PM  
11:40AM  
11:27AM  
11:15AM  
11:08AM  
10:57AM  
10:55AM  
10:24AM  
10:17AM  
08:45AM  
07:26AM  
May-16-22 04:31PM  
04:30PM  
04:26PM  
03:37PM  
02:53PM  
07:34AM  
07:00AM  
May-14-22 10:30AM  
07:04AM  
May-13-22 05:37PM  
02:08PM  
01:44PM  
10:41AM  
08:10AM  
07:00AM  
May-12-22 04:56PM  
03:41PM  
03:09PM  
10:25AM  
10:00AM  
10:00AM  
08:02AM  
02:45AM  
May-11-22 02:12PM  
02:08PM  
01:16PM  
01:12PM  
07:00AM  
May-10-22 09:00PM  
04:06PM  
02:47PM  
02:26PM  
12:06PM  
12:04PM  
11:33AM  
11:28AM  
11:23AM  
10:06AM  
09:51AM  
09:00AM  
08:30AM  
07:00AM  
06:56AM  
06:56AM  
06:52AM  
06:45AM  
06:20AM  
May-09-22 04:10PM  
09:31AM  
08:19AM  
06:45AM  
06:15AM  
06:11AM  
06:00AM  
06:00AM  
May-07-22 08:25AM  
08:07AM  
07:03AM  
May-06-22 04:15PM  
01:13PM  
11:30AM  
10:45AM  
10:07AM  
09:02AM  
06:56AM  
06:45AM  
06:39AM  
May-05-22 06:12PM  
11:11AM  
10:04AM  
07:36AM  
05:55AM  
May-04-22 04:39PM  
10:11AM  
07:04AM  
07:04AM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerMay 16Sale50.504,000202,00015,064May 17 07:48 AM
SAHNI PAYALExecutive Vice PresidentMay 13Sale49.841,40870,17517,372May 16 09:23 PM
Carapezzi William R JRExecutive Vice PresidentMay 12Sale50.0032,9081,645,40038,146May 13 05:38 PM
LANKLER DOUGLAS MExecutive Vice PresidentMay 12Sale49.4138,2731,891,06978,803May 13 05:19 PM
Dolsten MikaelPresident R&DMay 11Sale49.3263,9023,151,547333,342May 12 04:34 PM
Dolsten MikaelPresident R&DMar 03Option Exercise31.83102,4603,261,036396,578Mar 04 04:13 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise25.60127,1603,255,296649,918Mar 01 05:55 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise25.6063,5801,627,648172,880Mar 01 05:55 PM
DAMICO JENNIFER B.SVP & ControllerFeb 26Option Exercise25.609,713248,65326,120Mar 01 04:02 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise25.6077,7091,989,350174,507Mar 01 04:03 PM
McDermott MichaelExecutive Vice PresidentFeb 26Option Exercise25.6012,340315,90483,530Mar 01 04:03 PM
Carapezzi William R JRExecutive Vice PresidentFeb 26Option Exercise25.6021,193542,54187,363Mar 01 04:03 PM
Carapezzi William R JRExecutive Vice PresidentFeb 23Option Exercise27.3425,632700,77982,914Feb 25 05:06 PM
SAHNI PAYALExecutive Vice PresidentFeb 23Option Exercise27.3413,884379,58929,391Feb 25 06:27 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise27.3476,8952,102,309166,470Feb 25 06:29 PM
Hwang AngelaGroup PresidentFeb 23Option Exercise27.3421,359583,95521,359Feb 25 06:10 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise27.34115,3423,153,450181,659Feb 25 06:20 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise27.34153,7894,204,591636,977Feb 25 06:04 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise27.3435,457969,39491,301Feb 25 06:17 PM
DAMICO JENNIFER B.SVP & ControllerFeb 23Option Exercise27.3411,748321,19021,668Feb 25 05:46 PM
Dolsten MikaelPresident R&DDec 17Option Exercise30.1771,1872,147,712351,637Dec 21 06:31 PM
BOURLA ALBERTChairman & CEODec 17Option Exercise26.73123,0553,289,547246,444Dec 21 06:03 PM
JOHNSON RADY AExecutive Vice PresidentDec 03Sale53.4219,0001,015,04255,844Dec 06 05:18 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentDec 02Sale54.2641,3602,244,19487,280Dec 06 05:18 PM
SUSMAN SALLYExecutive Vice PresidentNov 26Sale54.5244,3082,415,57889,575Nov 30 04:30 PM
LANKLER DOUGLAS MExecutive Vice PresidentNov 26Sale54.3740,0002,174,78666,317Nov 30 04:30 PM
Hwang AngelaGroup PresidentNov 12Sale49.6026,1701,298,0021Nov 15 05:32 PM
Dolsten MikaelPresident R&DNov 11Option Exercise25.13199,5485,014,926339,506Nov 15 05:40 PM
Dolsten MikaelPresident R&DNov 11Sale50.2959,6643,000,647279,842Nov 15 05:40 PM
YOUNG JOHN DGroup PresidentNov 11Sale50.06150,0007,508,732312,704Nov 12 06:08 PM
DAMICO JENNIFER B.SVP & ControllerAug 13Sale48.301,66180,2269,769Aug 16 08:12 PM
DAMICO JENNIFER B.SVP & ControllerJul 30Sale42.862,500107,15011,430Aug 02 07:02 PM